Skip to main content
Archives of Endocrinology and Metabolism logoLink to Archives of Endocrinology and Metabolism
. 2020 Oct 8;64(5):636. doi: 10.20945/2359-3997000000305

Reference values of 25-hydroxyvitamin D revisited: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC)

PMCID: PMC10118957  PMID: 33047906

DOI: 10.20945/2359-3997000000258

Arch Endocrinol Metab. 2020;64(4):462-78

Where you read (TITLE):

Reference values of 25-hydroxyvitamin D revisited: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine (SBPC)

Should read:

Reference values of 25-hydroxyvitamin D revisited: a position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society of Clinical Pathology/Laboratory Medicine ( SBPC/ML )

Where you read (TEXT):

These assays include a first step in which 25(OH)D is dissociated from its carrier proteins. In a second step, the 25(OH)D in the sample competes with an analogue for the same sites of the ligand's assay [anti-25(OH)D or DBP antibodies] .

Should read:

These assays include a first step in which 25(OH)D is dissociated from its carrier proteins. In a second step, the 25(OH)D in the sample competes with an analogue for the same sites of the ligand's assay [anti-25(OH)D antibodies and DBP] .

Where you read:

Table 2. Clinical conditions and groups that benefit from 25-hydroxyvitamin (25[OH]D) concentrations above 30 ng/mL.

Groups Clinical Conditions
Elderly (> 65 years) Osteoporosis (primary or secondary)
Pregnant women Fractures due to fragility
Metabolic bone diseases (osteomalacia, osteogenesis imperfecta, primary hyperparathyroidism)
Secondary hyperparathyroidism
Sarcopenia
Recurring falls
Chronic renal disease
Malabsorption syndrome
Liver failure
Anorexia nervosa
Cancer

Should read:

Table 2. Clinical conditions and groups that benefit from 25-hydroxyvitamin (25[OH]D) concentrations above 30 ng/mL.

Groups Clinical Conditions
Elderly (> 65 years) Osteoporosis (primary or secondary)
Pregnant women Fractures due to fragility
Metabolic bone diseases (osteomalacia, osteogenesis imperfecta, primary hyperparathyroidism)
Secondary hyperparathyroidism
Sarcopenia
Recurring falls
Chronic renal disease
Malabsorption syndrome
Liver failure
Diabetes mellitus type 1
Cancer

Where you read:

Correspondence to:

Carolina Moreira

Rua Leão Júnior, 285

80060-000 – Curitiba, PR Brasil

carolina.aguiar.moreira@gmail.com

Should read:

Carolina Moreira

Av Agostinho Leão Júnior, 285

80060-000 – Curitiba, PR Brasil

carolina.aguiar.moreira@gmail.com


Articles from Archives of Endocrinology and Metabolism are provided here courtesy of Sociedade Brasileira de Endocrinologia e Metabologia

RESOURCES